SeekIn Receives CE Mark for its LeukoPrint Test for Leukemia

Shenzhen, China-based SeekIn has received a CE mark for its LeukoPrint diagnostic kit for the detection of leukemia.

The kit uses whole-gene sequencing to identify gene alternations that are important for diagnostic classification and risk stratification in leukemia patients, the company said.

SeekIn, which specializes in blood-based cancer early-detection and monitoring technology, said LeukoPrint can also be used for other types of hematological malignancies, such as multiple myeloma.